The Clorox Company (NYSE:CLX) Shares Sold by Woodline Partners LP

Woodline Partners LP lowered its stake in The Clorox Company (NYSE:CLX - Free Report) by 87.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,942 shares of the company's stock after selling 21,396 shares during the quarter. Woodline Partners LP's holdings in Clorox were worth $478,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Redwood Park Advisors LLC purchased a new position in shares of Clorox during the 4th quarter worth $26,000. Millstone Evans Group LLC acquired a new stake in Clorox in the 4th quarter valued at $31,000. Asset Planning Inc acquired a new stake in shares of Clorox during the fourth quarter valued at about $32,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Clorox during the fourth quarter valued at about $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in shares of Clorox during the fourth quarter valued at about $33,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Ratings Changes

A number of research firms recently commented on CLX. DA Davidson decreased their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company decreased their price target on Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Evercore ISI set a $140.00 price target on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. UBS Group decreased their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Finally, Morgan Stanley decreased their price target on Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $151.23.

Clorox Stock Performance

NYSE CLX traded up $0.77 during trading hours on Friday, reaching $131.76. The company's stock had a trading volume of 2,492,592 shares, compared to its average volume of 1,341,934. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The business has a 50-day simple moving average of $138.30 and a 200 day simple moving average of $151.14. The Clorox Company has a 52 week low of $129.19 and a 52 week high of $171.37. The stock has a market cap of $16.24 billion, a PE ratio of 36.00, a PEG ratio of 2.62 and a beta of 0.60.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business's quarterly revenue was down 8.0% on a year-over-year basis. During the same period last year, the firm posted $1.71 EPS. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Insider Activity

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The shares were bought at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the acquisition, the director now owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.57% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.